PRCT — PROCEPT BioRobotics Corp

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1588978 ·
Last close
$23.78
Market Cap
$1.37B
52W High
$38.11
52W Low
$16.67
ADV30
1,340,599
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 98,291,000 65,148,000 -27,376,000 -26,516,000 473,759,000 218,369,000 144,851,000
Jun 2026 94,498,000 62,379,000 -27,390,000 -26,861,000 479,352,000 227,914,000 139,282,000
Mar 2026 83,132,000 53,947,000 -32,606,000 -31,638,000 487,062,000 245,641,000 139,395,000
Dec 2025 76,383,000 46,313,000 -31,041,000 -29,845,000 508,081,000 286,503,000 142,211,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-76,690,000
Investing CF
$-8,384,000
Financing CF
$9,257,000
CapEx
$-8,384,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.02
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-726,572,000
Inventory
$81,410,000
Receivables
$105,030,000
ST Investments
—
EBIT TTM
$-111,267,000
Pretax Income TTM
$-114,677,000
Interest Exp TTM
$3,410,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$352,304,992
EBITDA
$-113,640,000
Free Cash Flow
$-44,437,376
Enterprise Value
$1,045,017,792
Total Cash
$218,368,992
Total Debt
$76,992,000
Shares Out
57,536,121
Trailing EPS
$-2.02
Book Value
$5.73
ROE
-32.4%
ROA
-15.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 308,054,000 -103,859,000 -95,572,000 508,081,000 142,211,000 365,870,000 -48,985,000
Dec 2024 224,498,000 -96,614,000 -91,413,000 534,017,000 131,797,000 402,220,000 -99,213,000
Dec 2023 136,191,000 -109,170,000 -105,897,000 404,717,000 123,965,000 280,752,000 -108,003,000
Dec 2022 75,014,000 -80,724,000 -87,154,000 309,329,000 112,257,000 197,072,000 -80,382,000

TTM Snapshot

Revenues TTM
$337,340,000
NetIncome TTM
$-109,756,000
OpCashFlow TTM
—
Assets (Latest)
$479,352,000
Forward EPS
$-1.17

Max Pain — expiry 2027-01-15

max pain strike: $15.00 · spot: $25.18 · call oi: 3,103 · put oi: 576
Expected Move to 2027-01-15: ±$5.75 (22.84%) — implied range $19.43 – $30.93 · ATM straddle on $25.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CDRE Cadre Holdings, Inc. $1.39B $32.41 —
BFLY Butterfly Network, Inc. $1.41B $5.75 —
NVCR NovoCure Ltd $1.30B $11.14 —
CNMD CONMED Corp $1.44B $48.39 —
ENOV Enovis CORP $1.57B $27.22 —

News headlines (Yahoo Finance, 1h cache)

PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
2026-11-18 21:05 · Yahoo
PROCEPT BioRobotics (PRCT) Stock Looks Overvalued Against Its Sales Story
2026-11-13 20:06 · Yahoo
PROCEPT BioRobotics (PRCT) Stock Dropped, So What Is Driving Attention Now?
2026-11-06 18:19 · Yahoo
PROCEPT BioRobotics Corp (PRCT) (Q3 2026) Earnings Call Highlights: Revenue Grows 18% as Hydros ...
2026-11-05 07:14 · Yahoo
PROCEPT BioRobotics Q3 Earnings Call Highlights
2026-11-05 05:14 · Yahoo
PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates
2026-11-04 23:45 · Yahoo
PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
2026-11-04 21:05 · Yahoo
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2026-10-28 13:00 · Yahoo
PROCEPT BioRobotics (PRCT) Stock May Be Fully Priced On Cash Flow Hopes
2026-10-25 15:07 · Yahoo
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
2026-10-12 20:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.